Zions Bancorporation’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $158K | Buy |
672
+80
| +14% | +$18.8K | 0.01% | 337 |
|
|
2024
Q3 | $163K | Buy |
592
+572
| +2,860% | +$157K | 0.01% | 339 |
|
|
2024
Q2 | $4.86K | Buy |
20
+6
| +43% | +$1.46K | ﹤0.01% | 758 |
|
|
2024
Q1 | $2.09K | Sell |
14
-5
| -26% | -$747 | ﹤0.01% | 828 |
|
|
2023
Q4 | $3.64K | Sell |
19
-5
| -21% | -$957 | ﹤0.01% | 777 |
|
|
2023
Q3 | $4.25K | Hold |
24
| – | – | ﹤0.01% | 746 |
|
|
2023
Q2 | $4.56K | Buy |
24
+10
| +71% | +$1.9K | ﹤0.01% | 740 |
|
|
2023
Q1 | $2.8K | Sell |
14
-7
| -33% | -$1.4K | ﹤0.01% | 796 |
|
|
2022
Q4 | $4.99K | Sell |
21
-1
| -5% | -$238 | ﹤0.01% | 855 |
|
|
2022
Q3 | $4K | Buy |
22
+3
| +16% | +$545 | ﹤0.01% | 796 |
|
|
2022
Q2 | $3K | Buy |
+19
| New | +$3K | ﹤0.01% | 917 |
|
|
2021
Q1 | – | Sell |
-32
| Closed | -$4K | – | 952 |
|
|
2020
Q4 | $4K | Hold |
32
| – | – | ﹤0.01% | 804 |
|
|
2020
Q3 | $5K | Hold |
32
| – | – | ﹤0.01% | 802 |
|
|
2020
Q2 | $5K | Hold |
32
| – | – | ﹤0.01% | 734 |
|
|
2020
Q1 | $3K | Hold |
32
| – | – | ﹤0.01% | 751 |
|
|
2019
Q4 | $4K | Hold |
32
| – | – | ﹤0.01% | 809 |
|
|
2019
Q3 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 828 |
|
|
2019
Q2 | – | Sell |
-45
| Closed | -$4K | – | 920 |
|
|
2019
Q1 | $4K | Buy |
45
+32
| +246% | +$2.84K | ﹤0.01% | 780 |
|
|
2018
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 437 |
|
|
2016
Q4 | – | Sell |
-19
| Closed | -$1K | – | 843 |
|
|
2016
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 770 |
|
|
2016
Q2 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 753 |
|